7.85
price up icon1.68%   0.13
after-market Handel nachbörslich: 7.82 -0.03 -0.38%
loading
Schlusskurs vom Vortag:
$7.72
Offen:
$7.98
24-Stunden-Volumen:
46,393
Relative Volume:
1.10
Marktkapitalisierung:
$128.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.82M
KGV:
-0.3068
EPS:
-25.5891
Netto-Cashflow:
$-66.04M
1W Leistung:
-2.12%
1M Leistung:
+1.29%
6M Leistung:
+52.72%
1J Leistung:
+131.56%
1-Tages-Spanne:
Value
$7.57
$8.0847
1-Wochen-Bereich:
Value
$7.57
$8.19
52-Wochen-Spanne:
Value
$3.345
$9.99

Elicio Therapeutics Inc Stock (ELTX) Company Profile

Name
Firmenname
Elicio Therapeutics Inc
Name
Telefon
(857) 209-0050
Name
Adresse
451 D STREET, 5TH FLOOR, BOSTON
Name
Mitarbeiter
26
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
ELTX's Discussions on Twitter

Vergleichen Sie ELTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ELTX
Elicio Therapeutics Inc
7.85 128.30M 0 -33.82M -66.04M -25.59
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Elicio Therapeutics Inc Aktie (ELTX) Neueste Nachrichten

pulisher
Jun 18, 2025

Elicio Therapeutics Secures Strategic Financing As Pivotal Cancer Trial Data Approaches - Barchart.com

Jun 18, 2025
pulisher
Jun 17, 2025

Elicio Therapeutics to Host Virtual KOL Event on June 25, - GlobeNewswire

Jun 17, 2025
pulisher
Jun 17, 2025

Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer - GlobeNewswire Inc.

Jun 17, 2025
pulisher
Jun 04, 2025

Elicio secures $10 million to extend cash runway By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Elicio Therapeutics Secures $10 Million in Financing - citybiz

Jun 04, 2025
pulisher
Jun 04, 2025

Elicio Therapeutics Gets $10 Million Note Financing - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Elicio secures $10 million to extend cash runway - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Elicio Therapeutics Secures $10M Financing for Operations - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Elicio Therapeutics (ELTX) Secures $10M Financing to Extend Operations | ELTX Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Elicio Therapeutics Lands $10M Funding to Advance Revolutionary Cancer Vaccine Through Critical Trial Phase - Stock Titan

Jun 04, 2025
pulisher
May 29, 2025

When the Price of (ELTX) Talks, People Listen - news.stocktradersdaily.com

May 29, 2025
pulisher
May 20, 2025

Elicio Therapeutics announces board election results By Investing.com - Investing.com Nigeria

May 20, 2025
pulisher
May 20, 2025

Elicio Therapeutics Elects New Directors at Annual Meeting - TipRanks

May 20, 2025
pulisher
May 20, 2025

Elicio Therapeutics announces board election results - Investing.com

May 20, 2025
pulisher
May 14, 2025

Elicio Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

Elicio's (ELTX) ELI-002 Interim Analysis Anticipated in Phase 2 Trial | ELTX Stock News - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Elicio Therapeutics: Q1 Earnings Snapshot - CTPost

May 13, 2025
pulisher
May 13, 2025

Elicio Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire

May 13, 2025
pulisher
May 08, 2025

Learn to Evaluate (ELTX) using the Charts - news.stocktradersdaily.com

May 08, 2025
pulisher
May 01, 2025

Here's Why Elicio Therapeutics (ELTX) Could be Great Choice for a Bottom Fisher - Yahoo Finance

May 01, 2025
pulisher
Apr 23, 2025

Long Term Trading Analysis for (ELTX) - news.stocktradersdaily.com

Apr 23, 2025
pulisher
Apr 16, 2025

Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires - GlobeNewswire

Apr 16, 2025
pulisher
Apr 16, 2025

Key Executive Appointment: Elicio Therapeutics Names New Chief Strategy and Financial Officer - Stock Titan

Apr 16, 2025
pulisher
Apr 15, 2025

Elicio Therapeutics grants inducement award to new chief strategy and financial officer - MSN

Apr 15, 2025
pulisher
Apr 06, 2025

(ELTX) Investment Report - news.stocktradersdaily.com

Apr 06, 2025
pulisher
Apr 04, 2025

Elicio Therapeutics (ELTX) Upgraded to Buy: Here's What You Should Know - MSN

Apr 04, 2025
pulisher
Apr 04, 2025

Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Apr 04, 2025
pulisher
Apr 04, 2025

Earnings Preview: What To Expect From Johnson & Johnson's Report - Barchart.com

Apr 04, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Elicio Therapeutics Advances Cancer Immunotherapy Pipeline - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

Elicio signals delay in mid-stage cancer vaccine study; shares slump - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Elicio Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Elicio Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Elicio's Latest Financial Results Reveal Key Clinical Milestones and 28.9-Month Survival Data - Stock Titan

Mar 31, 2025
pulisher
Mar 27, 2025

(ELTX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 26, 2025

ELICIO THERAPEUTICS Earnings Preview: Recent $ELTX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 26, 2025
pulisher
Mar 24, 2025

Elicio Therapeutics Names Preetam Shah CFO -March 24, 2025 at 08:17 am EDT - MarketScreener

Mar 24, 2025
pulisher
Mar 24, 2025

Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

Elicio Therapeutics Hires CFO From Cidara Therapeutics - MarketWatch

Mar 24, 2025
pulisher
Mar 24, 2025

Elicio Therapeutics Appoints New Chief Strategy and Financial Officer - TipRanks

Mar 24, 2025
pulisher
Mar 24, 2025

Elicio Therapeutics appoints new CSFO amid clinical trials - Investing.com

Mar 24, 2025
pulisher
Mar 24, 2025

Strategic Move: Elicio Strengthens Leadership Team Ahead of Crucial Phase 2 Trial Results - Stock Titan

Mar 24, 2025
pulisher
Mar 22, 2025

Elicio Therapeutics, Inc. (NASDAQ:ELTX) surges 13%; individual investors who own 49% shares profited along with insiders - simplywall.st

Mar 22, 2025

Finanzdaten der Elicio Therapeutics Inc-Aktie (ELTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):